Immuneering Corp (IMRX) Peer Comparison

$4.99

$-0.22 (-4.22%)

As on 28-Aug-2026 16:18EDT

Market cap

$323 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.8

Div. Yield

0 %

Edit

	Immuneering Corp (IMRX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	323	16,765	16,261	13,492	11,994
Revenue ($ Mln)	0	2,782	1,054	2,436	670
Net Profit ($ Mln)	-57.28	491.50	755.85	860.62	-319.95
Net Margin (%)	-15,867.83	17.67	71.69	35.33	-47.79
RoE (%)	-27.99	110.09	--	42.98	-71.14
Price to Earnings	--	35.25	19.00	17.40	--
Price-To-Book	1.77	39.29	9.76	7.42	26.87

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Immuneering Corp (IMRX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	0.36	2,782.29	1,054.37	2,435.92	669.50
Cost of Revenue	1.06	1,982.07	103.47	85.67	19.14
Gross Profit	-0.70	760.62	588.53	2,236.43	829.45
Operating Expenses	62.68	216.81	841.45	1,378.74	895.93
Operating Profit (EBIT)	-63.47	583.40	109.45	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-57.28	598.92	101.11	1,035.47	-252.08
Provision for Tax	0.00	107.42	-654.74	174.84	20.05
Profit after Tax (Net Income)	-57.28	491.50	755.85	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Immuneering Corp (IMRX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	190.74	433.86	1,435.90	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	3.20	187.89	384.48	288.55	1,362.63
Current Liabilities	8.12	1,435.43	464.70	361.93	283.35
Total Liabilities	231.99	1,975.47	1,302.02	2,844.42	1,385.30

Assets ($ Mln)

	Immuneering Corp (IMRX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	44.06	1,006.90	895.24	1,243.41	440.60
Current Assets	157.99	1,050.29	1,389.84	1,250.82	1,671.41
Total Assets	231.99	1,975.47	1,302.02	2,844.42	1,385.30
Total Debt*	3.63	120.10	449.89	165.93	864.07
Net Current Assets	149.87	-385.14	0.00	888.90	1,388.07

Cashflow ($ Mln)

	Immuneering Corp (IMRX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-45.34	713.22	51.77	884.27	179.55
Cash Flow from Investing Activities	-88.74	-31.14	-8.15	350.44	-129.29
Cash from Financing Activities	226.58	-860.39	34.89	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Immuneering Corp (IMRX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-41.83	53.56	-30.01	32.82	-0.17
ROE (%)	-27.99	110.09	163.18	42.98	-71.14
ROA (%)	-44.45	15.64	26.53	29.32	-16.12
EBIT Margin (%)	-17,219.28	21.13	5.73	31.04	-0.77
Net Margin (%)	-15,867.83	17.67	71.69	35.33	-47.79
Cash Profit Margin (%)	-0.05	0.00	0.00	0.00	0.00

Growth Ratios

	Immuneering Corp (IMRX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	-50.30	24.67	114.85	9.23	12.22
EBIT Growth (%)	2.22	18.70	136.39	-3.99	93.17
Net Profit Growth (%)	7.81	17.50	378.76	42.89	-115.58
EPS Growth (%)	45.56	26.84	353.27	50.42	-73.87
Book Value Growth (%)	266.64	164.02	816.12	-0.70	-13.57

Valuation Ratios

	Immuneering Corp (IMRX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-7.59	36.06	-59.76	15.79	-2,869.63
Price / Book Value	1.77	39.29	9.76	7.42	26.87
Dividend Yield (%)	0.00	0.00	0.00	0.00	0.00
EV/EBITDA	-2.51	27.43	211.41	12.12	-81.53
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Immuneering Corp (IMRX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.00	0.00	0.05	0.00	0.09
Current Ratio	19.47	0.73	2.99	3.46	5.90
Quick Ratio	19.47	0.73	2.32	3.38	5.90
Interest Coverage	--	--	1.62	--	-1.72

Operating Efficiency Ratios

	Immuneering Corp (IMRX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	935.67	15.88	21.25	13.74	1.28
Asset Turnover	0.00	0.89	0.37	0.83	0.34
Receivable days	--	50.42	85.52	43.48	1.50
Inventory Days	--	--	1,056.70	96.17	--
Payable days	914.91	6.26	331.01	147.97	221.81
Cash Conversion Cycle	--	--	811.21	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly